Article Versions Notes

Markova L, Cvetko E, Ugwoke CK, Horvat S, Umek N, Stopar Pintarič T. The Influence of Diabetic Peripheral Neuropathy on the Duration of Sciatic Nerve Block with 1.3% Liposomal Bupivacaine and 0.25% Bupivacaine Hydrochloride in a Mouse Model. Pharmaceutics. 2022; 14(9):1824. https://doi.org/10.3390/pharmaceutics14091824

Markova, Liljana, Erika Cvetko, Chiedozie Kenneth Ugwoke, Simon Horvat, Nejc Umek, and Tatjana Stopar Pintarič. 2022. "The Influence of Diabetic Peripheral Neuropathy on the Duration of Sciatic Nerve Block with 1.3% Liposomal Bupivacaine and 0.25% Bupivacaine Hydrochloride in a Mouse Model" Pharmaceutics 14, no. 9: 1824. https://doi.org/10.3390/pharmaceutics14091824

Markova, L., Cvetko, E., Ugwoke, C. K., Horvat, S., Umek, N., & Stopar Pintarič, T. (2022). The Influence of Diabetic Peripheral Neuropathy on the Duration of Sciatic Nerve Block with 1.3% Liposomal Bupivacaine and 0.25% Bupivacaine Hydrochloride in a Mouse Model. Pharmaceutics, 14(9), 1824. https://doi.org/10.3390/pharmaceutics14091824